Search Results

Press Releases

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

October 30, 2024

·

4 min read

Press Releases

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

November 26, 2024

·

1 min read

Biotech Bay

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 2024 Truist Securities MedTech Conference in Boston, Massachusetts.

June 3, 2024

·

1 min read

Business

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

October 9, 2024

·

1 min read

Business

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

PROCEPT BioRobotics® Corporation, a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, reported unaudited financial results for the quarter ended March 31, 2024.

May 1, 2024

·

11 min read

Press Releases

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

October 28, 2024

·

11 min read

Press Releases

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

October 7, 2024

·

6 min read

Business

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results

PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the year ended December 31, 2023.

February 27, 2024

·

13 min read

Biotech Bay

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

PROCEPT BioRobotics today announced that 12 abstracts highlighting its Aquablation therapy for the treatment of benign prostatic hyperplasia (BPH) will be presented at the American Urological Association (AUA) Annual Meeting in San Antonio, Texas, from May 3 - 6, 2024.

April 23, 2024

·

7 min read

Business

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

August 28, 2024

·

1 min read